AAAAAA
Results: 1-25/42
Authors:
MAILMAN RB
NICHOLS DE
Citation: Rb. Mailman et De. Nichols, DOPAMINE D1 RECEPTOR AGONISTS AS ANTIPARKINSON DRUGS, Trends in pharmacological sciences, 19(7), 1998, pp. 255-256
Authors:
MONTAGUE DM
DRAGO J
MAILMAN RB
Citation: Dm. Montague et al., INTRINSIC ACTIVITY OF D-1 AGONISTS IN THE HETEROZYGOUS GENOTYPE OF D-1 RECEPTOR-DEFICIENT MICE, The FASEB journal, 12(4), 1998, pp. 905-905
Authors:
PRIOLEAU C
LAWLER CP
MAILMAN RB
Citation: C. Prioleau et al., INTERACTIONS OF THE NOVEL ANTIPSYCHOTIC, ARIPIPRAZOLE, AT THE D-2 DOPAMINE-RECEPTOR, The FASEB journal, 12(4), 1998, pp. 2651-2651
Authors:
SMITH DR
STRIPLIN CD
GELLER AM
MAILMAN RB
DRAGO J
LAWLER CP
GALLAGHER M
Citation: Dr. Smith et al., BEHAVIORAL-ASSESSMENT OF MICE LACKING D-1A DOPAMINE-RECEPTORS, Neuroscience, 86(1), 1998, pp. 135-146
Authors:
LEWIS MM
WATTS VJ
LAWLER CP
NICHOLS DE
MAILMAN RB
Citation: Mm. Lewis et al., HOMOLOGOUS DESENSITIZATION OF THE D-1A DOPAMINE-RECEPTOR - EFFICACY IN CAUSING DESENSITIZATION DISSOCIATES FROM BOTH RECEPTOR OCCUPANCY ANDFUNCTIONAL POTENCY, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 345-353
Authors:
BUNIN MA
PRIOLEAU C
MAILMAN RB
WIGHTMAN RM
Citation: Ma. Bunin et al., RELEASE AND UPTAKE RATES OF 5-HYDROXYTRYPTAMINE IN THE DORSAL RAPHE AND SUBSTANTIA-NIGRA RETICULATA OF THE RAT-BRAIN, Journal of neurochemistry, 70(3), 1998, pp. 1077-1087
Authors:
MONTE AP
MARONALEWICKA D
LEWIS MM
MAILMAN RB
WAINSCOTT DB
NELSON DL
NICHOLS DE
Citation: Ap. Monte et al., SUBSTITUTED NAPHTHOFURANS AS HALLUCINOGENIC PHENETHYLAMINE-ERGOLINE HYBRID MOLECULES WITH UNEXPECTED MUSCARINIC ANTAGONIST ACTIVITY, Journal of medicinal chemistry, 41(12), 1998, pp. 2134-2145
Authors:
DUNCAN GE
LEIPZIG JN
MAILMAN RB
LIEBERMAN JA
Citation: Ge. Duncan et al., DIFFERENTIAL-EFFECTS OF CLOZAPINE AND HALOPERIDOL ON KETAMINE-INDUCEDBRAIN METABOLIC-ACTIVATION, Brain research, 812(1-2), 1998, pp. 65-75
Authors:
LIEBERMAN JA
MAILMAN RB
DUNCAN G
SIKICH L
CHAKOS M
NICHOLS DE
KRAUS JE
Citation: Ja. Lieberman et al., SEROTONERGIC BASIS OF ANTIPSYCHOTIC DRUG EFFECTS IN SCHIZOPHRENIA, Biological psychiatry, 44(11), 1998, pp. 1099-1117
Authors:
BODFISH JW
MCCULLER WR
MADISON JM
REGISTER M
MAILMAN RB
LEWIS MH
Citation: Jw. Bodfish et al., PLACEBO, DOUBLE-BLIND EVALUATION OF LONG-TERM NALTREXONE TREATMENT EFFECTS FOR ADULTS WITH MENTAL-RETARDATION AND SELF-INJURY, Journal of developmental and physical disabilities, 9(2), 1997, pp. 135-152
Authors:
NEGASH K
NICHOLS DE
WATTS VJ
MAILMAN RB
Citation: K. Negash et al., FURTHER DEFINITION OF THE D-1 DOPAMINE-RECEPTOR PHARMACOPHORE - SYNTHESIS OF 8,9,13B-HEXAHYDRO-5H-BENZO[D]NAPHTH[2,1-B]AZEPINES AS RIGID ANALOGS OF BETA-PHENYLDOPAMINE, Journal of medicinal chemistry, 40(14), 1997, pp. 2140-2147
Authors:
SMITH HP
NICHOLD DE
MAILMAN RB
LAWLER CP
Citation: Hp. Smith et al., LOCOMOTOR INHIBITION, YAWNING AND VACUOUS CHEWING INDUCED BY A NOVEL DOPAMINE D-2 POSTSYNAPTIC RECEPTOR AGONIST, European journal of pharmacology, 323(1), 1997, pp. 27-36
Authors:
WALKER QD
MAILMAN RB
Citation: Qd. Walker et Rb. Mailman, TRIADIMEFON AND TRIADIMENOL - EFFECTS ON MONOAMINE UPTAKE AND RELEASE, Toxicology and applied pharmacology, 139(2), 1996, pp. 227-233
Authors:
GHOSH D
SNYDER SE
WATTS VJ
MAILMAN RB
NICHOLS DE
Citation: D. Ghosh et al., 2,3,7,11B-TETRAHYDRO-1H-NAPH[1,2,3-DE]ISOQUINOLINE - A POTENT FULL DOPAMINE D-1 AGONIST CONTAINING A RIGID BETA-PHENYLDOPAMINE PHARMACOPHORE, Journal of medicinal chemistry, 39(2), 1996, pp. 549-555
Authors:
MOTTOLA DM
LAITER S
WATTS VJ
TROPSHA A
WYRICK SD
NICHOLS DE
MAILMAN RB
Citation: Dm. Mottola et al., CONFORMATIONAL-ANALYSIS OF D-1 DOPAMINE-RECEPTOR AGONISTS - PHARMACOPHORE ASSESSMENT AND RECEPTOR MAPPING, Journal of medicinal chemistry, 39(1), 1996, pp. 285-296
Authors:
WATTS VJ
LAWLER CP
FOX DR
NEVE KA
NICHOLS DE
MAILMAN RB
Citation: Vj. Watts et al., LSD AND STRUCTURAL ANALOGS - PHARMACOLOGICAL EVALUATION AT D-1 DOPAMINE-RECEPTORS, Psychopharmacology, 118(4), 1995, pp. 401-409
Authors:
LAWLER CP
GILMORE JH
WATTS VJ
WALKER QD
SOUTHERLAND SB
COOK LL
MATHIS CA
MAILMAN RB
Citation: Cp. Lawler et al., INTERHEMISPHERIC MODULATION OF DOPAMINE-RECEPTOR INTERACTIONS IN UNILATERAL 6-OHDA RODENT MODEL, Synapse, 21(4), 1995, pp. 299-311
Authors:
WATTS VJ
LAWLER CP
GONZALES AJ
ZHOU QY
CIVELLI O
NICHOLS DE
MAILMAN RB
Citation: Vj. Watts et al., SPARE RECEPTORS AND INTRINSIC ACTIVITY - STUDIES WITH D-1 DOPAMINE-RECEPTOR AGONISTS, Synapse, 21(2), 1995, pp. 177-187
Authors:
GARIEPY JL
GENDREAU PL
MAILMAN RB
TANCER M
LEWIS MH
Citation: Jl. Gariepy et al., REARING CONDITIONS ALTER SOCIAL REACTIVITY AND D-1 DOPAMINE-RECEPTORSIN HIGH-AGGRESSIVE AND LOW-AGGRESSIVE MICE, Pharmacology, biochemistry and behavior, 51(4), 1995, pp. 767-773
Authors:
BLAKE BL
ROSE RL
MAILMAN RB
LEVI PE
HODGSON E
Citation: Bl. Blake et al., METABOLISM OF THIORIDAZINE BY MICROSOMAL MONOOXYGENASES - RELATIVE ROLES OF P450 AND FLAVIN-CONTAINING MONOOXYGENASE, Xenobiotica, 25(4), 1995, pp. 377-393
Authors:
GILMORE JH
WATTS VJ
LAWLER CP
NOLL EP
NICHOLS DE
MAILMAN RB
Citation: Jh. Gilmore et al., FULL DOPAMINE D-1 AGONISTS IN HUMAN CAUDATE - BIOCHEMICAL-PROPERTIES AND THERAPEUTIC IMPLICATIONS, Neuropharmacology, 34(5), 1995, pp. 481-488
Authors:
HEIDENREICH BA
MAILMAN RB
NICHOLS DE
NAPIER TC
Citation: Ba. Heidenreich et al., PARTIAL AND FULL DOPAMINE D-1 AGONISTS PRODUCE COMPARABLE INCREASES IN VENTRAL PALLIDAL NEURONAL-ACTIVITY - CONTRIBUTION OF ENDOGENOUS DOPAMINE, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 516-525
Authors:
BREWSTER WK
NICHOLS DE
WATTS VJ
RIGGS RM
MOTTOLA D
MAILMAN RB
Citation: Wk. Brewster et al., EVALUATION OF CIS AND TRANS-9 AND XY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINES AS STRUCTURALLY RIGID, SELECTIVE D-1 DOPAMINE-RECEPTORLIGANDS, Journal of medicinal chemistry, 38(2), 1995, pp. 318-327
Authors:
WYRICK SD
BOOTH RG
MYERS AM
OWENS CE
BUCHOLTZ EC
HOOPER PC
KULA NS
BALDESSARINI RJ
MAILMAN RB
Citation: Sd. Wyrick et al., 1-PHENYL-3-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENES AND RELATED DERIVATIVES AS LIGANDS FOR THE NEUROMODULATORY SIGMA(3) RECEPTOR - FURTHER STRUCTURE-ACTIVITY-RELATIONSHIPS, Journal of medicinal chemistry, 38(19), 1995, pp. 3857-3864
Authors:
KNOERZER TA
WATTS VJ
NICHOLS DE
MAILMAN RB
Citation: Ta. Knoerzer et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF A SERIES OF SUBSTITUTED BENZO[A]PHENANTHRIDINES AS AGONISTS AT D-1 AND D-2 DOPAMINE-RECEPTORS, Journal of medicinal chemistry, 38(16), 1995, pp. 3062-3070